33 studies found for:    " November 10, 2010":" December 10, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects
Conditions: HIV;   HIV Infection
Intervention: Biological: SB-728-T
2 Completed
Has Results
Two Approaches to Routine HIV Testing in a Hospital Emergency Department
Condition: HIV Infections
Interventions: Procedure: Oral HIV screening;   Procedure: Fingerstick HIV screening
3 Unknown  Improving Antiretroviral Medication Adherence Among HIV-infected Youth: Phase I
Condition: HIV Infection
Intervention:
4 Completed The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
Conditions: HIV Infections;   Depression;   Mild Cognitive Impairment
Interventions: Drug: raltegravir single dose;   Drug: ginkgo biloba multiple dose
5 Recruiting A Randomized Controlled Trial of the Bruthas Project
Condition: HIV Infection
Interventions: Behavioral: Bruthas Project;   Behavioral: Standard HIV Testing and Counseling
6 Active, not recruiting
Has Results
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF
Condition: HIV-1 Infection
Interventions: Drug: FTC/RPV/TDF;   Drug: PI;   Drug: RTV;   Drug: NRTIs
7 Recruiting Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Conditions: HIV;   AIDS;   Opioid Dependence;   Drug Dependence
Intervention: Drug: Extended-Release Naltrexone
8 Completed Addressing Psychosocial Needs and HIV Risk in Indian MSM
Conditions: HIV/STI Risk;   HIV/STI Incidence
Intervention: Behavioral: Behavioral intervention
9 Recruiting Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: HIV Infection;   Recurrent Anal Cancer;   Recurrent Breast Cancer;   Recurrent Esophageal Cancer;   Recurrent Gastric Cancer;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Anal Cancer;   Stage IV Breast Cancer;   Stage IV Esophageal Cancer;   Stage IV Gastric Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vorinostat;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Drug: carboplatin;   Drug: paclitaxel
10 Active, not recruiting The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)
Condition: HIV Infections
Intervention: Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
11 Unknown  Impact of Raltegravir on the Viral Reservoirs
Condition: HIV Infection
Intervention:
12 Completed Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight
Condition: HIV Infection
Intervention: Drug: Nevirapine
13 Withdrawn A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium
Condition: HIV Infections
Interventions: Drug: Maraviroc/Dapivirine Gel;   Drug: Dapivirine Vaginal Gel;   Drug: Maraviroc Vaginal Gel;   Drug: Matching Placebo Gel
14 Unknown  Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.
Condition: HIV Integrase, HIV Protease.
Interventions: Drug: Raltegravir;   Drug: Darunavir
15 Active, not recruiting Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
Conditions: HIV;   Cardiovascular Disease
Interventions: Drug: raltegravir plus truvada;   Drug: Darunavir, ritonavir, tenofovir/emtricitabine (Truvada)
16 Terminated Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
Condition: HIV
Intervention: Drug: CYT107
17 Completed
Has Results
Will Having Alcohol Treatment Improve Functioning?
Conditions: HIV;   Alcoholism
Interventions: Drug: Naltrexone, 50mg, once per day for 4 months;   Other: Sugar pill, 50mg, once per day for 4 months
18 Withdrawn A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir
Condition: HIV
Interventions: Drug: Lopinavir;   Drug: Atazanavir
19 Completed IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites
Conditions: IRIS;   HIV
Intervention:
20 Unknown  Vitamin D in HIV-Infected Patients on HAART
Conditions: Vitamin D Deficiency;   HIV
Intervention: Dietary Supplement: Vitamin D

Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results
Indicates status has not been verified in more than two years